High sustained virologic response rates in hepatitis C virus genotype 3 patients with and without cirrhosis treated with daclatasvir/sofosbuvir or velpatasvir/sofosbuvir ± ribavirin according to baseline resistance analysis

Saved in:
Bibliographic Details
Published in:Journal of hepatology Vol. 66; no. 1; p. S83
Main Authors: Vermehren, J, Dietz, J, Peiffer, K.-H, Weiler, N, Mücke, V, Dultz, G, Welsch, C, Zeuzem, S, Welzel, T.M, Sarrazin, C
Format: Journal Article
Language:English
Published: 2017
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:0168-8278
DOI:10.1016/S0168-8278(17)30431-2